Abstract
Statins exert several beneficial effects on patients with peripheral arterial disease, whether managed conservatively or undergoing open surgical/endovascular procedures. Statins improve perioperative and long-term mortality and morbidity rates in these patients. There is also evidence that statins improve infrainguinal bypass graft patency rates and are associated with reduced graft restenosis and amputation rates in these procedures. This review considers the beneficial effects of statins on patients undergoing infrainguinal bypass graft procedures and discusses the implicated pathomechanisms.
Keywords: Statins, peripheral arterial disease, infrainguinal bypass graft operation perioperative mortality and morbidity, peripheral endovascular procedures, 3-hydroxy-3-methylglutaryl coenzyme A, abdominal aortic aneurysms, extremity functions
Current Vascular Pharmacology
Title:Statins and Infrainguinal Vascular Bypass Procedures
Volume: 11 Issue: 1
Author(s): Kosmas I. Paraskevas, Athanasios D. Giannoukas and Dimitri P. Mikhailidis
Affiliation:
Keywords: Statins, peripheral arterial disease, infrainguinal bypass graft operation perioperative mortality and morbidity, peripheral endovascular procedures, 3-hydroxy-3-methylglutaryl coenzyme A, abdominal aortic aneurysms, extremity functions
Abstract: Statins exert several beneficial effects on patients with peripheral arterial disease, whether managed conservatively or undergoing open surgical/endovascular procedures. Statins improve perioperative and long-term mortality and morbidity rates in these patients. There is also evidence that statins improve infrainguinal bypass graft patency rates and are associated with reduced graft restenosis and amputation rates in these procedures. This review considers the beneficial effects of statins on patients undergoing infrainguinal bypass graft procedures and discusses the implicated pathomechanisms.
Export Options
About this article
Cite this article as:
I. Paraskevas Kosmas, D. Giannoukas Athanasios and P. Mikhailidis Dimitri, Statins and Infrainguinal Vascular Bypass Procedures, Current Vascular Pharmacology 2013; 11 (1) . https://dx.doi.org/10.2174/1570161111309010051
DOI https://dx.doi.org/10.2174/1570161111309010051 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stroke in Women - Oral Contraception, Pregnancy, and Hormone Replacement Therapy
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Biomarkers (Discontinued) Anesthetic Cardioprotection: The Role of Adenosine
Current Pharmaceutical Design Dyslipidemia as a Risk Factor for Ischemic Stroke
Current Topics in Medicinal Chemistry Proinflammatory Gene Polymorphisms and Ischemic Stroke
Current Pharmaceutical Design Alanine Aminotransferase Predicts Outcomes in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage
Current Neurovascular Research Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued) An Evidence-Based Review of Off-Label Uses of Polidocanol
Current Clinical Pharmacology Contributory Role of Matrix Metalloproteinases in Cardiovascular Remodeling
Current Drug Targets - Cardiovascular & Hematological Disorders Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors
Recent Patents on CNS Drug Discovery (Discontinued) 9.4T Magnetic Resonance Imaging of the Mouse Circle of Willis Enables Serial Characterization of Flow-Induced Vascular Remodeling by Computational Fluid Dynamics
Current Neurovascular Research Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion
Current Pharmaceutical Design The Role of Small, Dense Low-Density-Lipoproteins in Non-Coronary Forms of Atherosclerosis
Vascular Disease Prevention (Discontinued) The Posterior Perforated Substance: A Brain Mystery Wrapped in an Enigma
Current Topics in Medicinal Chemistry The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
Current Pharmaceutical Design Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances
Central Nervous System Agents in Medicinal Chemistry Purinergic Signalling and Endothelium
Current Vascular Pharmacology Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk
Current Pharmaceutical Design Microdialysis in Neurointensive Care
Current Pharmaceutical Design Bioactive Compound and Nanotechnology: A Novel Delivery Perspective for Diabetic Retinopathy
Current Bioactive Compounds